FLT3 and acute myeloid leukemia: Our previous work also reported potent activity of CDDD11-8 against a limited number of other kinases, in particular the fms-like tyrosine kinase 3 (FLT3) protein, and its mutant form (FLT3-ITD), a known driver and therapeutic target in acute myeloid leukaemia [30].